Latest & greatest articles for cannabis

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cannabis or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cannabis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cannabis

1. Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews

Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews Cannabinoids, cannabis, and cannabis-based medicines for pain management: an overview of systematic reviews - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest (...) : Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Your RSS Feed Name of RSS Feed: Number of items displayed: Create RSS Cancel RSS Link Copy Actions Cite Display options Display options Format Share Permalink Copy Page navigation Pain Actions . 2020 May 28. doi: 10.1097/j.pain.0000000000001941. Online ahead of print. Cannabinoids, cannabis

2020 EvidenceUpdates

2. Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association Full Text available with Trip Pro

Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association | Circulation Search Search Hello Guest! Login to your account Email Password Keep me logged in Search Search August 2020 July 2020 June 2020 May 2020 April 2020 March 2020 February 2020 January 2020 This site uses cookies. By continuing (...) to browse this site you are agreeing to our use of cookies. Free Access Review Article Share on Jump to Free Access Review Article Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association , PharmD, MSPH, FAHA, Chair , MD, MHS, FAHA, Vice Chair , MD, PhD , PhD , PhD , MD, MSc, FAHA , RN, PhD, FAHA , MD, PhD , MD, FAHA Robert L. Page II , Larry A. Allen , Robert A. Kloner , Colin R. Carriker , Catherine Martel , Alanna A. Morris

2020 American Heart Association

3. A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome

13;1(1):CD007393. doi: 10.1002/14651858.CD007393.pub4. Cochrane Database Syst Rev. 2017. PMID: 28085183 Free PMC article. Review. Show more similar articles References Gray KM, Watson NL, Christie DK. Challenges in quantifying marijuana use. Am J Addict 2009;18:178-9. Simonetto DA, Oxentenko AS, Herman ML, Szostek JH. Cannabinoid hyperemesis: a case series of 98 patients. Mayo Clin Proc 2012;87:114-9. Sorensen CJ, DeSanto K, Borgelt L, Phillips KT, Monte AA. Cannabinoid hyperemesis syndrome (...) A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving situation. Get the latest public health information from CDC

2020 EvidenceUpdates

4. Effect of Inhaled Cannabis for Pain in Adults With Sickle Cell Disease: A Randomized Clinical Trial Full Text available with Trip Pro

(SCD) is characterized by chronic pain and episodic acute pain caused by vasoocclusive crises, often requiring high doses of opioids for prolonged periods. In humanized mouse models of SCD, a synthetic cannabinoid has been found to attenuate both chronic and acute hyperalgesia. The effect of cannabis on chronic pain in adults with SCD is unknown. Objective: To determine whether inhaled cannabis is more effective than inhaled placebo in relieving chronic pain in adults with SCD. Design, setting (...) . Roy NB, Fortin PM, Bull KR, Doree C, Trivella M, Hopewell S, Estcourt LJ. Roy NB, et al. Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2. Cochrane Database Syst Rev. 2017. PMID: 28672087 Free PMC article. Review. Show more similar articles References National Conference of State Legislatures State medical marijuana laws. Accessed May 31, 2019. Kosiba JD, Maisto SA, Ditre JW. Patient-reported use of medical cannabis for pain, anxiety, and depression

2020 EvidenceUpdates

5. Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report

with maternal marijuana use in the first trimester, but not for the second or third trimester was observed. As no new evidence was found in the updated search, there continues to be insufficient evidence to demonstrate an association between cannabis smoking and the incidence of cancer in offspring. Conclusion: There is insufficient evidence to demonstrate an association between parental cannabis use and subsequent risk of developing any malignancies in offspring. 7.Are cannabis or cannabinoids an effective (...) Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study Report Evidence Summary 23-2 A Quality Initiative of the Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario) Cancer and the Health Effects of Cannabis and Cannabinoids: An update of the systematic review by the National Academies of Sciences, Engineering, and Medicine (2017) Consensus Study

2020 Cancer Care Ontario

6. COVID 19, Alcohol and Cannabis Use

among critically ill patients admitted to an intensive care unit with an infection (Gacouin et al., 2020). The effects of cannabis use and cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), on immune functioning are complex and not yet well understood. However, a growing body of preclinical studies and several studies involving humans suggest that THC and CBD can affect the immune system, including suppressing its ability to mount a response to fight off infections (Cabral (...) COVID 19, Alcohol and Cannabis Use www.ccsa.ca • www.ccdus.ca Canadian Centre on Substance Use and Addiction • Centre canadien sur les dépendances et l’usage de substances Page 1 COVID-19, Alcohol and Cannabis Use This backgrounder to the infographic, COVID-19, Alcohol and Cannabis Use, describes some of the evidence-based associations between COVID-19, alcohol and cannabis use. It is intended for a broad audience, including health professionals, policy makers and researchers

2020 Canadian Centre on Substance Abuse

7. Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis

Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library (...) displayed: Create RSS Cancel RSS Link Copy Actions Cite Share Permalink Copy Page navigation Reg Anesth Pain Med Actions . 2020 Jul;45(7):509-519. doi: 10.1136/rapm-2020-101340. Epub 2020 May 28. Analgesic efficacy of cannabinoids for acute pain management after surgery: a systematic review and meta-analysis , , , Affiliations Expand Affiliations 1 Anesthesiology and Pain Medicine - North York General Hospital & The Ottawa Hospital, University of Toronto, University of Ottawa, Toronto, Ottawa, Ontario

2020 EvidenceUpdates

8. Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial

Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine National Center for Biotechnology Information Show (...) Permalink Copy Page navigation Obstet Gynecol Actions . 2020 Jun;135(6):1289-1295. doi: 10.1097/AOG.0000000000003850. Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial , , , , , , , Affiliations Expand Affiliation 1 Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, Oregon. PMID: 32459420 DOI: Item in Clipboard Cannabinoids for Pain Control During Medical Abortion: A Randomized Controlled Trial Alyssa Covelli Colwill et al. Obstet

2020 EvidenceUpdates

9. Counselling adolescents and parents about cannabis: A primer for health professionals

Counselling adolescents and parents about cannabis: A primer for health professionals While cannabis use among adolescents is frequent in Canada, youth do recognize the potential harms, and increasingly expect knowledgeable health care providers to discuss substance use in everyday practice. This practice point provides sound, evidence-based tools to help health professionals address non-medical (recreational) cannabis use and its related risks. After highlighting how to make the clinical (...) setting a safe space for youth to talk about psychoactive substances, specific strategies for approaching cannabis use in effective, developmentally appropriate ways are described. Consistent with current literature, screening questionnaires to help structure discussion and identify adolescents who may benefit from more specialized interventions are recommended. Because one in six adolescents who experiments with cannabis goes on to misuse it, appraising their willingness to change risky behaviours

2020 Canadian Paediatric Society

10. COVID-19 and Cannabis Smoking and Vaping: Four Things You Should Know

on the lung and immune defenses. In ElSohly (ed.), Marijuana and the Cannabinoids, pp. 253–275. Totowa, New Jersey: Humana Press. Taylor, D. R., Poulton, R., Moffit, T. E., Ramankutty, P., & Sears, M. R. (2000). The respiratory effects of cannabis dependence in young adults. Addiction, 95(11), 1669–1677. Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications: A systematic review (...) Group: https://www.cannabisrehab.org/ Cannabis Resources • Canadian Institute for Substance Use Research, Safer Cannabis Use: https://www.heretohelp.bc.ca/infosheet/safer-cannabis-use-marijuana-hash-hash-oil • Centre for Addiction and Mental Health, Canada’s Lower-Risk Cannabis Use Guidelines: https://www.camh.ca/-/media/files/pdfs---reports-and-books---research/canadas-lower-risk- guidelines-cannabis-pdf.pdf • Government of Canada, Cannabis in Canada: Get the facts: https://www.canada.ca/en

2020 Canadian Centre on Substance Abuse

11. Use of cannabinoids in cancer patients Full Text available with Trip Pro

f , x W. Burke Affiliations Stony Brook Medicine, Stony Brook, NY, USA c DOI: | Publication History Published online: January 13, 2020 Accepted: December 11, 2019 ; Received: October 24, 2019 ; To view the full text, please login as a subscribed user or . Click to view the full text on ScienceDirect. Highlights • Tetrahydrocannabinol (THC), cannabidiol (CBD) and cannabinol (CBN) affect the human endocannabinoid system. • Cannabinoids reduce chemotherapy induced nausea or vomiting (CINV (...) ) and neuropathic pain. • Each state has its own regulations for medical and recreational cannabis use. • Effects of cannabinoids on chemotherapy, immunotherapy, and tumor growth remain under investigation. • Providers should focus indications, alternatives, risks and benefits of medical cannabis use to make appropriate referrals. Keywords: , , , , , To access this article, please choose from the options below Log In Register Purchase access to this article Claim Access If you are a current subscriber

2020 Society of Gynecologic Oncology

12. Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Full Text available with Trip Pro

Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance - Canadian Journal of Cardiology Go search , P357-372, March 01, 2020 Powered By Mendeley Share on Canadian Cardiovascular Society Position Statement on Postural Orthostatic (...) Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance Satish R. Raj Correspondence Corresponding author: Dr Satish R. Raj, GAC70 HRIC Building, University of Calgary, 3280 Hospital Dr NW, Calgary, Alberta T2N 4Z6, Canada. Tel.: +1-403-210-6152; fax: +1-403-210-9444. Affiliations Department of Cardiac Sciences, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada Juan C. Guzman Affiliations Department of Medicine, McMaster University

2020 Canadian Cardiovascular Society

13. Canadian guidelines on cannabis use disorder among older adults

of Canada. Health Canada. Information for Health Care Professionals: Cannabis (marihuana, marijuana) and the Cannabinoids. Ottawa, ON: Health Canada; 2018. Retrieved from https://www.canada.ca/content/dam/ hc-sc/documents/services/drugs-medication/cannabis/ information-medical-practitioners/information-health- care-professionals-cannabis-cannabinoids-eng.pdf 13. Hackam DG. Cannabis and stroke: systematic appraisal of case reports. Stroke. 2015;46(3):852–56. 14. Hemachandra D, McKetin R, Cherbuin N, et (...) withdrawal symptoms in older adults, as well as the presentation of can- nabis hyperemesis syndrome. (9) Cannabis is a plant that contains hundreds of com- pounds, including cannabinoids which act on the endogenous cannabinoid (endocannabinoid) system. Certain cannabi- noids act by influencing reward, motivation, and substance- related cues. Notably, delta-9-tetrahydro-cannabinol (THC) and cannabidiol (CBD) are two cannabinoids that have been studied the most. They exert various effects by binding

2020 CPG Infobase

14. Cannabis and Your Medications

Cannabis and Your Medications Cannabis can interact with your medications and affect your health. For more information, talk to your healthcare provider. Medications that can interact with cannabis PAIN medications HEART medications and BLOOD THINNERS SLEEPING PILLS ANTI-SEIZURE medications ANTI- DEPRESSANTS and ANTI-ANXIETY medications ANTIBIOTIC and ANTIFUNGAL medications ADHD medications Drugs to treat HIV/AIDS ALLERGY medications COLD and FLU medications HEARTBURN medications Learn about (...) the health effects of cannabis at ccsa.ca/cannabis and canada.ca/cannabis Cannabis and Your Medication © Canadian Centre on Substance Use and Addiction 2020

2020 Canadian Centre on Substance Abuse

15. Cannabis and Other Substances

Cannabis and Other Substances Cannabis and Other Substances Learn about the health effects of cannabis at ccsa.ca/cannabis and canada.ca/cannabis Using cannabis with alcohol can increase your risk of over-intoxication and impair your ability to drive safely. Smoking cannabis with tobacco increases exposure to chemicals that can further your risk of developing lung and heart disease. Using cannabis with drugs (e.g., MDMA, cocaine, opioids, heroin, etc.) can lead to interactions that can (...) be dangerous to your health. © Canadian Centre on Substance Use and Addiction 2020 Cannabis used with other substances can lead to negative impacts on your health. Using cannabis with tobacco can increase the risk for dependence on these substances more than smoking either one alone. If you choose to use cannabis, be aware of the risks of mixing with other substances. TOBACCO OTHER ALCOHOL

2020 Canadian Centre on Substance Abuse

16. Cannabis Use During Pregnancy and Lactation: A Practice Resources for Health Care Providers

) was enacted, establishing a framework for the possession, distribution, sale and production of cannabis in Canada. (5) Cannabis is defined in the Act to include marijuana, hashish, hash oil or any other preparation of the cannabis plant. (5) In 2016, 16.9% of Canadian women between the ages of 15-44 reported past year use of cannabis which was an increase from the self reported 12.6% in 2015. (6) In British Columbia (BC), approximately 3.5% of pregnant women and individuals reported cannabis use (...) -on-Obstetric-Practice/Marijuana- Use-During-Pregnancy-and-Lactation?IsMobileSet=false n Midwives Association of British Columbia. Is it safe to use weed during pregnancy? https://www.bcmidwives.com/cgi/page.cgi/_zine.html/News_Announcements/Is_it_ safe_to_use_weed_during_pregnancy_ n Canadian Association of Midwives. Cannabis Use during Pregnancy. https:// canadianmidwives.org/2018/10/15/cannabis-use-during-pregnancy/ n Champlain Maternal Newborn Regional Program (CMNRP). Cannabis and Lactation Discussion

2020 British Columbia Perinatal Health Program

17. Position Statement on the medicinal use of Cannabinoids in Pain Medicine

Position Statement on the medicinal use of Cannabinoids in Pain Medicine Faculty Position Statement on the medicinal use of Cannabinoids in Pain Medicine Update following the publication of NICE Guidance NG144 (11 November 2019) This statement is focused on the issues relating to cannabis derived medicinal products in relation to Pain Medicine. It does not comment on other areas of medical practice or recreational use, which lie outside our remit. The issue of cannabis, its extracts (...) , Radbruch L, Petzke F, Häuser W. Cannabis-based medicines for chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012182. DOI: 10.1002 /14651858.CD012182.pub2 3. Stockings E, Campbell G, Hall WD, Nielsen S, Zagic D, Rahman R, et al. Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies. PAIN. 2018;159(10):1932-54. 4. National Academies

2020 Faculty of Pain Medicine

18. Herbal cannabis and pharmaceutical cannabinoid treatment following motor vehicle accidents: A state of the science review

recommendation) — Nabilone is off-label for pain and has limited evidence of benefit. However, it is less expensive than nabiximols and dosing is more consistent than for smoked cannabis — Nabiximols is expensive and, in some provinces, only available through specialist prescribing or special authorization. However, nabiximols has better evidence than nabilone does -If considering medical cannabinoids, we recommend against medical marijuana (particularly smoked) as the initial product (strong recommendation (...) Herbal cannabis and pharmaceutical cannabinoid treatment following motor vehicle accidents: A state of the science review Herbal cannabis and pharmaceutical cannabinoid treatment following motor vehicle accidents: A state of the science review Final Report Carolyn J Green, PhD Ken L Bassett, MD, PhD Therapeutics Initiative University of British Columbia October 2018 Table of Contents 1.0 Developing a funding policy framework for ICBC insurance claims 1 1.1 Scientific medical knowledge

2020 Therapeutics Letter

19. Clearing the Smoke on Cannabis: Respiratory and Cardiovascular Effects of Cannabis Smoking

). Potency trends of ?9-THC and other cannabinoids in confiscated marijuana from 1980–1997. Journal of Forensic Sciences, 45(1), 24–30. Exley, C., Begum, A., Woolley, M. P ., & Bloor, R. N. (2006). Aluminum in tobacco and cannabis and smoking- related disease. American Journal of Medicine, 119(3), 276.e9–276.e11. Gargani, Y., Bishop, P ., & Denning, D. W. (2011). Too many mouldy joints—marijuana and chronic pulmonary aspergillosis. Mediterranean Journal of Hematology and Infectious Diseases, 3(1 (...) Canada. (2015). Statement on Supreme Court of Canada decision in R. v. Smith. Retrieved January 11, 2016, from www.hc-sc.gc.ca/ dhp-mps/marihuana/info/licencedproducer- producteurautorise/decision-r-v-smith-eng.php. Clearing the Smoke on Cannabis: Respiratory Effects of Cannabis Smoking Kempker, J. A., Honig, E. G., & Martin, G. S. (2015). The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study. Annals

2020 Canadian Centre on Substance Abuse

20. Cannabis-based medicinal products

technology appraisal guidance on cannabidiol with clobazam for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Products covered by the guideline include: cannabis-based products for medicinal use as set out by the UK Government in the 2018 Regulations the licensed products delta-9-tetrahydrocannibinol combined with cannabidiol (Sativex) and nabilone plant-derived cannabinoids such as pure cannabidiol (CBD) synthetic compounds which are identical in structure to naturally (...) occurring cannabinoids such as delta-9-tetrahydrocannabinol (THC), for example, dronabinol. Who is it for? Who is it for? Healthcare professionals People taking cannabis-based medicinal products, their families and carers Cannabis-based medicinal products (NG144) © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 4 of 27Recommendations Recommendations People have the right to be involved in discussions and make informed

2019 National Institute for Health and Clinical Excellence - Clinical Guidelines